173 related articles for article (PubMed ID: 24410179)
1. Autonomic hypoactivity in boys with attention-deficit/hyperactivity disorder and the influence of methylphenidate.
Conzelmann A; Gerdes AB; Mucha RF; Weyers P; Lesch KP; Bähne CG; Fallgatter AJ; Renner TJ; Warnke A; Romanos M; Pauli P
World J Biol Psychiatry; 2014 Jan; 15(1):56-65. PubMed ID: 24410179
[TBL] [Abstract][Full Text] [Related]
2. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate normalizes emotional processing in adult patients with attention-deficit/hyperactivity disorder: preliminary findings.
Conzelmann A; Woidich E; Mucha RF; Weyers P; Jacob CP; Lesch KP; Pauli P
Brain Res; 2011 Mar; 1381():159-66. PubMed ID: 21215727
[TBL] [Abstract][Full Text] [Related]
4. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder.
Ozdag MF; Yorbik O; Ulas UH; Hamamcioglu K; Vural O
Int J Pediatr Otorhinolaryngol; 2004 Oct; 68(10):1267-72. PubMed ID: 15364497
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task.
Lawrence CA; Barry RJ; Clarke AR; Johnstone SJ; McCarthy R; Selikowitz M; Broyd SJ
Psychopharmacology (Berl); 2005 Nov; 183(1):81-91. PubMed ID: 16160877
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
[TBL] [Abstract][Full Text] [Related]
7. The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder.
Broyd SJ; Johnstone SJ; Barry RJ; Clarke AR; McCarthy R; Selikowitz M; Lawrence CA
Int J Psychophysiol; 2005 Oct; 58(1):47-58. PubMed ID: 15925419
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
[TBL] [Abstract][Full Text] [Related]
9. The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.
Kubas HA; Backenson EM; Wilcox G; Piercy JC; Hale JB
Postgrad Med; 2012 Sep; 124(5):33-48. PubMed ID: 23095424
[TBL] [Abstract][Full Text] [Related]
10. Heart rate variability and methylphenidate in children with ADHD.
Buchhorn R; Conzelmann A; Willaschek C; Störk D; Taurines R; Renner TJ
Atten Defic Hyperact Disord; 2012 Jun; 4(2):85-91. PubMed ID: 22328340
[TBL] [Abstract][Full Text] [Related]
11. Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment.
Gürkan K; Bilgiç A; Türkoglu S; Kiliç BG; Aysev A; Uslu R
J Psychopharmacol; 2010 Dec; 24(12):1810-8. PubMed ID: 19939861
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate and emotional-motivational processing in attention-deficit/hyperactivity disorder.
Conzelmann A; Woidich E; Mucha RF; Weyers P; Müller M; Lesch KP; Jacob CP; Pauli P
J Neural Transm (Vienna); 2016 Aug; 123(8):971-9. PubMed ID: 26852138
[TBL] [Abstract][Full Text] [Related]
13. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.
Rösler M; Retz W; Fischer R; Ose C; Alm B; Deckert J; Philipsen A; Herpertz S; Ammer R
World J Biol Psychiatry; 2010 Aug; 11(5):709-18. PubMed ID: 20353312
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
[TBL] [Abstract][Full Text] [Related]
15. Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS.
Monden Y; Dan H; Nagashima M; Dan I; Kyutoku Y; Okamoto M; Yamagata T; Momoi MY; Watanabe E
Clin Neurophysiol; 2012 Jun; 123(6):1147-57. PubMed ID: 22088661
[TBL] [Abstract][Full Text] [Related]
16. Response to emotional stimuli in boys with conduct disorder.
Herpertz SC; Mueller B; Qunaibi M; Lichterfeld C; Konrad K; Herpertz-Dahlmann B
Am J Psychiatry; 2005 Jun; 162(6):1100-7. PubMed ID: 15930058
[TBL] [Abstract][Full Text] [Related]
17. Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder.
Groom MJ; Liddle EB; Scerif G; Liddle PF; Batty MJ; Liotti M; Hollis CP
J Child Psychol Psychiatry; 2013 Aug; 54(8):836-45. PubMed ID: 23662815
[TBL] [Abstract][Full Text] [Related]
18. Childhood methylphenidate treatment of ADHD and response to affective stimuli.
Schlochtermeier L; Stoy M; Schlagenhauf F; Wrase J; Park SQ; Friedel E; Huss M; Lehmkuhl U; Heinz A; Ströhle A
Eur Neuropsychopharmacol; 2011 Aug; 21(8):646-54. PubMed ID: 20570115
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
20. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
